U.S. to buy another 200 million doses of Moderna's COVID-19 vaccine
Marketwatch -

Shares of Moderna Inc. were down 1.2% in premarket trading on Wednesday after the company said the U.S. has agreed to buy an additional 200 million doses of its COVID-19 vaccine. This agreement includes the option to purchase other COVID-19 vaccine candidates that Moderna is developing. This could include booster shots, Moderna executives said in a news release. In total, the U.S. has ordered 500 million doses of the company's mRNA vaccine. Moderna's stock has soared 92.9% this year, while the...

Read this story at

Loading...

Related Articles